Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: LIVER CIRRHOSIS - DRUG THERAPY , . Treffer: 5
2018
Korda, D; Lenard, ZM; Gerlei, Z; Jakab, Z; Haboub-Sandil, A; Wagner, L; Varga, M; Cseprekal, O; Marton, A; Horvathy, D; Takacs, S; Doros, A; Mathe, Z
Shear-wave elastography for the assessment of liver fibrosis in liver transplant recipients treated for hepatitis C virus recurrence.
Eur J Gastroenterol Hepatol. 2018; 30(1):27-32
Doi: 10.1097/MEG.0000000000001003
Web of Science
PubMed
FullText
FullText_MUG
2016
Horvath, A; Leber, B; Schmerboeck, B; Tawdrous, M; Zettel, G; Hartl, A; Madl, T; Stryeck, S; Fuchs, D; Lemesch, S; Douschan, P; Krones, E; Spindelboeck, W; Durchschein, F; Rainer, F; Zollner, G; Stauber, RE; Fickert, P; Stiegler, P; Stadlbauer, V
Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis.
Aliment Pharmacol Ther. 2016; 44(9):926-935
Doi: 10.1111/apt.13788
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Sombetzki, M; Fuchs, CD; Fickert, P; Österreicher, CH; Mueller, M; Claudel, T; Loebermann, M; Engelmann, R; Langner, C; Sahin, E; Schwinge, D; Guenther, ND; Schramm, C; Mueller-Hilke, B; Reisinger, EC; Trauner, M
24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis.
J Hepatol. 2015; 62(4):871-878
Doi: 10.1016/j.jhep.2014.11.020
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2014
Mandorfer, M; Bota, S; Schwabl, P; Bucsics, T; Pfisterer, N; Kruzik, M; Hagmann, M; Blacky, A; Ferlitsch, A; Sieghart, W; Trauner, M; Peck-Radosavljevic, M; Reiberger, T
Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis.
Gastroenterology. 2014; 146(7): 1680-1690.
Doi: 10.1053/j.gastro.2014.03.005
Web of Science
PubMed
FullText
FullText_MUG
2012
Moustafa, T; Fickert, P; Magnes, C; Guelly, C; Thueringer, A; Frank, S; Kratky, D; Sattler, W; Reicher, H; Sinner, F; Gumhold, J; Silbert, D; Fauler, G; Höfler, G; Lass, A; Zechner, R; Trauner, M
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
Gastroenterology. 2012; 142(1):140-151
Doi: 10.1053/j.gastro.2011.09.051
Web of Science
PubMed
FullText
FullText_MUG